Erasca, Inc. (ERAS)

NASDAQ

$15,47

$+0,09

(+0,57%)

Pre-Market

Erasca, Inc. (ERAS) Live Price Chart

Last updated: ⁦2026-10-13 12:26:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Erasca, Inc. (ERAS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $15,47, with a market capitalization of $5,61B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2,11 to $24,28. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$5,61B
Open	$15,39
Day's High	$24,47
Day's Low	$1,01
Previous Close	$15,46
Volume	371,00
Average Volume	4,37M
P/E Ratio	--
52-Week High	$24,28
52-Week Low	$2,11
Dividend Yield	--
Earnings Date	--

Erasca, Inc. (ERAS) Pre-Market Stock Price

Erasca, Inc. (ERAS) is trading at $15,47 in pre-market trading as of 2026-10-13 12:23:00, up 0,08% ($0,01) from the previous close of $15,46

Pre-market trading shows how investors are pricing ERAS before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

Erasca, Inc. (ERAS) 7-Day Stock Price Change

Over the past seven days, Erasca, Inc. (ERAS) moved from $14,74 to $15,47, representing a gain of 4,97% ($0,73).

The stock traded between $13,78 and $16,20 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.

The average daily volume was 6,13 million shares, up versus the previous seven-day period, indicating higher trading activity.

ERAS 52-Week Price Position

Position in Range: 60,3%

52W Low$2,11

52W High$24,28

ERAS is currently trading at $15,47, placing it 60,3% of the way from its 52-week low of $2,11 to its 52-week high of $24,28. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Erasca, Inc. (ERAS)?

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnostic programs aligned with three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes two clinical-stage programs (ERAS-0015, a pan-RAS molecular glue; and ERAS-4001, a pan-KRAS inhibitor), and ERAS-12, a discovery-stage program.

Erasca, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	103
Exchange	NASDAQ
Company Website	https://www.erasca.com

How to Buy Erasca, Inc. (ERAS) Stock on MEXC

Eligible investors can buy real shares of Erasca, Inc. (ERAS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ERAS and Place Your Order

Open the RealStocks trading page and search for ERAS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Erasca, Inc. (ERAS) stock price today?

Erasca, Inc. (ERAS) is currently trading at $ 15,47, up 0,08% ($0,01) from the previous close of $ 15,46. Intraday prices update in real time during regular trading hours.

2.Is ERAS stock going up or down today?

As of 2026-10-13 12:23:00, ERAS is trading at $ 15,47, up 0,08% ($0,01) from its previous close of $ 15,46. The stock has traded between $ 1,01 and $ 24,47 during today’s regular session. Past price movements do not guarantee future results.

3.What is ERAS pre-market price?

As of 2026-10-13 12:23:00, ERAS is trading at $ 15,47 in pre-market trading, up 0,08% ($0,01) from the previous close of $ 15,46. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ERAS after-hours price?

As of 2026-10-13 12:23:00, ERAS is trading at $ 15,40 in after-hours trading, down 0,41% ($0,06) from the regular-session close of $ 15,46. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ERAS stock trading now?

ERAS trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ERAS sit relative to its 52-week high and low?

Over the past 52 weeks, ERAS has traded between a low of $ 2,11 and a high of $ 24,28. At $ 15,47, the stock is positioned 60,3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Erasca, Inc. in?

Erasca, Inc. (ERAS) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Erasca, Inc.'s market capitalization and where is it listed?

Erasca, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 5,61B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ERAS valued in terms of P/E ratio and EPS?

ERAS trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0,82. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Erasca, Inc. pay a dividend?

Erasca, Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.